Adding the "medicines' back into personalized medicine to improve cancer treatment outcomes

被引：3
|
作者：
Martin, Jennifer H. [1 ,2 ]
Phillips, Elizabeth [3 ,4 ]
Thomas, David [5 ,6 ]
Somogyi, Andrew A. [7 ,8 ]
机构：
[1] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia
[2] Univ Queensland, Diamantina Inst, Woolloongabba, Qld, Australia
[3] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[4] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia
[5] St Vincents Hosp, Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia
[6] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia
[7] Univ Adelaide, Fac Hlth Sci, Discipline Pharmacol, Adelaide, SA 5001, Australia
[8] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2015年 / 80卷 / 05期
关键词：
CELL LUNG-CANCER; INHIBITION; ABACAVIR; KINASE; TUMORS;
D O I：
10.1111/bcp.12690
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：929 / 931
页数：3
相关论文
共 50 条
  • [1] Personalized medicine and back-allogeneic exosomes for cancer immunotherapy
    Samuel, M.
    Gabrielsson, S.
    JOURNAL OF INTERNAL MEDICINE, 2021, 289 (02) : 138 - 146
  • [2] Is it prime time for personalized medicine in cancer treatment?
    Kho, Patricia S.
    Chua, Wei
    Moore, Melissa M.
    Clark, Stephen J.
    PERSONALIZED MEDICINE, 2010, 7 (04) : 387 - 397
  • [3] Pilot Studies for Personalized Cancer Medicine: Focusing on the Patient for Treatment Selection
    De Mattos-Arruda, Leticia
    Rodon, Jordi
    ONCOLOGIST, 2013, 18 (11): : 1180 - 1188
  • [4] Personalized cancer medicine and the future of pathology
    Moch, H.
    Blank, P. R.
    Dietel, M.
    Elmberger, G.
    Kerr, K. M.
    Palacios, J.
    Penault-Llorca, F.
    Rossi, G.
    Szucs, T. D.
    VIRCHOWS ARCHIV, 2012, 460 (01) : 3 - 8
  • [5] Limits to Personalized Cancer Medicine
    Tannock, Ian F.
    Hickman, John A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (13): : 1289 - 1294
  • [6] Personalized medicine of esophageal cancer
    Wang, Lei
    Yang, Hui-Yi
    Zheng, Yong-Qing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (03) : 343 - 347
  • [7] Personalized treatment of prostate cancer: better knowledge of the patient, the disease and the medicine
    Aoun, Fouad
    El Rassy, Elie
    Assi, Tarek
    Kattan, Joseph
    FUTURE ONCOLOGY, 2016, 12 (20) : 2359 - 2361
  • [8] Impact of Genomics on Personalized Cancer Medicine
    Arteaga, Carlos L.
    Baselga, Jose
    CLINICAL CANCER RESEARCH, 2012, 18 (03) : 612 - 618
  • [9] Ovarian Cancer Immunotherapy and Personalized Medicine
    Morand, Susan
    Devanaboyina, Monika
    Staats, Hannah
    Stanbery, Laura
    Nemunaitis, John
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [10] Personalized immunotherapy in cancer precision medicine
    Kiyotani, Kazuma
    Toyoshima, Yujiro
    Nakamura, Yusuke
    CANCER BIOLOGY & MEDICINE, 2021, 18 (04) : 955 - 965
12345